DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive: In the prospective multicenter study reported here, 109 CML patients achieving standard criteria for TFR attempt were closely monitored for the presence of residual PB CD26+LSCs together with any clinical or molecular evidence of disease relapse.